Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growth.
Schumacher
G
G
Department of General-, Visceral-, and Transplantation Surgery, Charité Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany.
Oidtmann
M
M
Rosewicz
S
S
Langrehr
J
J
Jonas
S
S
Mueller
A R
AR
Rueggeberg
A
A
Neuhaus
R
R
Bahra
M
M
Jacob
D
D
Gerlach
H
H
Neuhaus
P
P
D006528:Carcinoma, Hepatocellular / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008113:Liver Neoplasms / Q000473:pathology*; D020123:Sirolimus / Q000494:pharmacology*; D016559:Tacrolimus / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D007166:Immunosuppressive Agents; D020123:Sirolimus; D016559:Tacrolimus